Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative study of CNR1 and CNR2 cannabinoid receptors expression levels in COVID-19 patients with and without diabetes mellitus: Recommendations for future research targets.
Aghamahdi F, Shafiee A, Rostami S, Mokhames Z, Safavi M, Yaslianifard S, Siami Z, Kabir K, Azizi G, Bakhtiyari M, Mozhgani SH. Aghamahdi F, et al. Diabetes Metab Syndr. 2022 May;16(5):102499. doi: 10.1016/j.dsx.2022.102499. Epub 2022 May 7. Diabetes Metab Syndr. 2022. PMID: 35580523 Free PMC article.
Immunological Evaluation of Pediatric Patients with Polyautoimmunity.
Mahdavi FS, Tavakol M, Aghamahdi F, Sadri H, Chavoshzadeh Z, Jamee M, Noorian S, Alaei MR, Ashkevari P, Anaya JM, Abolhassani H, Ochs HD, Azizi G. Mahdavi FS, et al. Among authors: aghamahdi f. Endocr Metab Immune Disord Drug Targets. 2023 Sep 12. doi: 10.2174/1871530323666230912124951. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37702233
Diagnostic Approach to the Patients with Suspected Primary Immunodeficiency.
Tavakol M, Jamee M, Azizi G, Sadri H, Bagheri Y, Zaki-Dizaji M, Mahdavi FS, Jadidi-Niaragh F, Tajfirooz S, Kamali AN, Aghamahdi F, Noorian S, Kojidi HT, Mosavian M, Matani R, Dolatshahi E, Porrostami K, Elahimehr N, Fatemi-Abhari M, Sharifi L, Arjmand R, Haghi S, Zainaldain H, Yazdani R, Shaghaghi M, Abolhassani H, Aghamohammadi A. Tavakol M, et al. Among authors: aghamahdi f. Endocr Metab Immune Disord Drug Targets. 2020;20(2):157-171. doi: 10.2174/1871530319666190828125316. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31456526 Review.
Clinical, Immunologic and Molecular Spectrum of Patients with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome: A Systematic Review.
Kiaee F, Zaki-Dizaji M, Hafezi N, Almasi-Hashiani A, Hamedifar H, Sabzevari A, Shirkani A, Zian Z, Jadidi-Niaragh F, Aghamahdi F, Goudarzvand M, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Kiaee F, et al. Among authors: aghamahdi f. Endocr Metab Immune Disord Drug Targets. 2021;21(4):664-672. doi: 10.2174/1871530320666200613204426. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 32533820
Autoimmunity in monogenic combined immune deficiencies with associated or syndromic features.
Sharifinejad N, Azizi G, Chavoshzadeh Z, Mahdaviani SA, Alan MS, Tavakol M, Sadri H, Nabavi M, Ebrahimi SS, Shirkani A, Vosughi Motlagh A, Safarirad M, Aghamahdi F, Nazari F, Delavari S, Jamee M, Fayyaz F, Samimisedeh P, Matani R, Esmaeili M, Yazdani R, Rezaei N, Abolhassani H. Sharifinejad N, et al. Among authors: aghamahdi f. Front Immunol. 2022 Dec 5;13:1023127. doi: 10.3389/fimmu.2022.1023127. eCollection 2022. Front Immunol. 2022. PMID: 36544766 Free PMC article.
Optimal Frequency to Screen Celiac Disease amongst Patients with Type 1 Diabetes Mellitus: A Multicenter Study.
Moravej H, Zamanfar D, Aghamahdi F, Hashemipour M, Mirrashidi FS, Ghaemi N, Eshraghi P, Ilkhanipoor H, Amirhakimi A, Yazdani N, Asl SN, Hashemian S, Raoofat A, Vazirian MV, Ebrahimzadeh H. Moravej H, et al. Among authors: aghamahdi f. Prim Care Diabetes. 2021 Dec;15(6):1100-1103. doi: 10.1016/j.pcd.2021.08.011. Epub 2021 Sep 6. Prim Care Diabetes. 2021. PMID: 34503936
17 results